1. Sam AP, Fokkens JG. The drug delivery system: adding therapeutic and economic value to pharmacotherapy. Pharma Tech Europe. 1997; Part 1, 9(5): 36–40, & 1997; Part II, 9(6): 58–66.
2. Langer R. Drug delivery and targeting. Nature. 1998; 392: supp. 5–10.
3. EU Guideline: Excipients in the dossier for application for marketing authorization of a medicinal product (3AQ9A). In: The Rules Governing Medicinal Products in the European Union. Luxembourg; EudraLex, Office for Official Publications of the European Union: 1988; Volume 3A, 67–74.
4. Notice to Applicants, The Rules Governing Medicinal Products in the European Union, Vol. 3A, Guidelines for Medicinal products for human use, Quality and biotechnology. Luxembourg; EudraLex, Office of Official Publications of the European Union: 1998.
5. Jones TM. The influence of physical characteristics of excipients on the design and preparation of tablets and excipients. The influence of physical characteristics of excipients on the design and preparation of tablets and excipients. 1977; 39(5): 469–476.